Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dobbs

Showing results (141-150 of 208) with videos related to

Pageof 21
Sort By:
British Journal of Clinical Pharmacology|March 1, 1991
Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesiaS G Bowes, P K Clark, A Charlett, et al.
Gut Pathogens|October 23, 2012
Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance studyR John Dobbs, André Charlett, Sylvia M Dobbs, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2013
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patientsC Blaecher, A Smet, B Flahou, et al.
International Journal of Molecular Sciences|December 17, 2024
Non-<i>Helicobacter pylori Helicobacters</i>, a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species SpecificityWenjing Wang, Melvyn Smith, Richard Ellis, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonismC Kirollos, A Charlett, S G Bowes, et al.
Frontiers in Medicine|September 27, 2019
<i>Helicobacter suis</i> Is Associated With Mortality in Parkinson's DiseaseAisha D Augustin, Antonella Savio, Amanda Nevel, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonismC Kirollos, A Charlett, C J O'Neill, et al.
Helicobacter|August 18, 2005
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonismR John Dobbs, Sylvia M Dobbs, Clive Weller, et al.
The Journal of Clinical Investigation|September 17, 2003
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivityThomas Stratmann, Natalia Martin-Orozco, Valérie Mallet-Designe, et al.
Gut Pathogens|November 28, 2009
Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established diseaseAndré Charlett, R John Dobbs, Sylvia M Dobbs, et al.
Pageof 21

Showing results (141-150 of 208) with videos related to

Sort By:
Pageof 21
British Journal of Clinical Pharmacology|March 1, 1991
Objective outcome criteria in trials of anti-parkinsonian therapy in the elderly: sensitivity, specificity and reliability of measures of brady- and hypo-kinesiaS G Bowes, P K Clark, A Charlett, et al.
Gut Pathogens|October 23, 2012
Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance studyR John Dobbs, André Charlett, Sylvia M Dobbs, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2013
Significantly higher frequency of Helicobacter suis in patients with idiopathic parkinsonism than in control patientsC Blaecher, A Smet, B Flahou, et al.
International Journal of Molecular Sciences|December 17, 2024
Non-<i>Helicobacter pylori Helicobacters</i>, a Treatable Provocateur of Parkinson's Disease: Hypothesis, Evidence and Species SpecificityWenjing Wang, Melvyn Smith, Richard Ellis, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonismC Kirollos, A Charlett, S G Bowes, et al.
Frontiers in Medicine|September 27, 2019
<i>Helicobacter suis</i> Is Associated With Mortality in Parkinson's DiseaseAisha D Augustin, Antonella Savio, Amanda Nevel, et al.
British Journal of Clinical Pharmacology|June 1, 1996
Objective measurement of activation of rigidity: diagnostic, pathogenetic and therapeutic implications in parkinsonismC Kirollos, A Charlett, C J O'Neill, et al.
Helicobacter|August 18, 2005
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonismR John Dobbs, Sylvia M Dobbs, Clive Weller, et al.
The Journal of Clinical Investigation|September 17, 2003
Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivityThomas Stratmann, Natalia Martin-Orozco, Valérie Mallet-Designe, et al.
Gut Pathogens|November 28, 2009
Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established diseaseAndré Charlett, R John Dobbs, Sylvia M Dobbs, et al.
Pageof 21